Nicholas Smedira, MD

Appointed
1994

Education & Fellowships

Graduate School - Case Western Reserve University School of Medicine
Cleveland, OH
2017

Fellowship - University of California San Francisco Medical Center
Cardiothoracic Surgery
San Francisco, CA
1994

Fellowship - Cleveland Clinic
Cardiothoracic Surgery
Cleveland, OH
1994

Medical Education - University of California San Francisco Medical Center
Cardiothoracic Surgery
San Francisco, CA
1992

Residency - University of California San Francisco Medical Center
General Surgery
San Francisco, CA
1991

Internship - University of California San Francisco Medical Center
General Surgery
San Francisco, CA
1985

Medical Education - University of Rochester School of Medicine and Dentistry
Rochester, NY
1984

Undergraduate - University of Rochester
Rochester, NY
1980

Additional Training

• Executive management course
• Professional development course
• Six Sigma
  
  
  
   

Professional Highlights

• Polly and W. Neil Rossborough Term Chair in Cardiac Transplantation
• Nursing-Physician Excellence Florence Nightingale Award, Cleveland Clinic  
• Professor of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Certifications

• Thoracic Surgery - Thoracic and Cardiac Surgery

Specialty Interests

Heart transplantation, heart-lung transplant, ventricular assist device, ECMO (Extracorporeal Membrane Oxygenation), heart failure surgery, heart valve surgery, off-pump bypass surgery, myectomy, surgery for thoracic aortic aneurysm

Awards & Honors

• 2007 –  Present Polly and W. Neil Rossborough Term Chair in Heart Transplantation Research
• 2002 – 2014 Best Doctors, Cleveland Magazine
• 2007 Innovator Award, Cleveland Clinic
• 2004 Teacher of the Year, Cleveland Clinic, Department of Cardiovascular and Thoracic Surgery
• 2003 Nursing-Physician Excellence Florence Nightingale Award, Cleveland Clinic

Innovations & Patents

• Syncardia Cardiowest Total Artificial Heart

Memberships

• Editorial Board, The Journal of Thoracic and Cardiovascular Surgery
• Western Thoracic Surgical Association 
• Cytosorbents, Inc., Medical Advisory Board
• Fellow, American College of Cardiology
• Fellow, American College of Chest Physicians
• Fellow, American College of Surgeons
• American Association of Thoracic Surgeons
• Membership Committee, American Association of Thoracic Surgeons
• Fellow, American Heart Association
• Society of Thoracic Surgeons
• Cardiac Transplantation Surgeon and Representative, International Society for Heart and Lung Transplantation, Heart Failure and Transplant
• Committee of the American College of Cardiology
• International Society for Heart and Lung Transplantation
• LifeBanc Medical Advisory Committee
• Surgical Representative, Ohio-American College of Cardiology
• Writing Committee, ACCF/AHA Guidelines for the Diagnosis and Treatment of Hypertrophic  Cardiomyopathy

See publications for Nicholas Smedira, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/18/2024, Dr. Smedira has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.